Effects of Statins on 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition Beyond Low-Density Lipoprotein Cholesterol
Data up to Jan 2025
Total Citations Per Year
Abstract
References (113)
Calcium's Role in Mechanotransduction during Muscle Development
2014 • 14,293 citations
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 • 7,450 citations
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
1995 • 7,378 citations
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 • 6,780 citations
Rho GTPases and the Actin Cytoskeleton
1998 • 6,129 citations
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
2000 • 5,760 citations
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 • 5,442 citations
Regulation of the mevalonate pathway
1990 • 5,282 citations
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
1987 • 5,027 citations
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 • 4,752 citations
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 • 3,816 citations
Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant Stress
2000 • 3,760 citations
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
1999 • 3,529 citations
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
1995 • 3,524 citations
Nitric oxide: an endogenous modulator of leukocyte adhesion.
1991 • 3,079 citations
The acute phase response
1994 • 2,927 citations
Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension
1997 • 2,847 citations
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
1999 • 2,577 citations
Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes<SUBTITLE>The MIRACL Study: A Randomized Controlled Trial</SUBTITLE>
2001 • 2,473 citations
Rho GTPases and signaling networks
1997 • 2,380 citations
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 • 2,343 citations
Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.
1989 • 2,183 citations
Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease
1971 • 2,055 citations
Molecular Bases of the Acute Coronary Syndromes
1995 • 2,049 citations
Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?
2014 • 1,880 citations
PLEIOTROPIC EFFECTS OF STATINS
2004 • 1,860 citations
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
1998 • 1,860 citations
Multiple Risk Factor Intervention Trial
1982 • 1,670 citations
Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events
2001 • 1,537 citations
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein
1999 • 1,488 citations
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.
2000 • 1,427 citations
Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels
1998 • 1,398 citations
The Lipid Research Clinics Coronary Primary Prevention Trial Results
1984 • 1,373 citations
Statins as a newly recognized type of immunomodulator
2000 • 1,371 citations
Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells
2003 • 1,303 citations
Effect of Pravastatin on Outcomes after Cardiac Transplantation
1995 • 1,302 citations
Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
2001 • 1,290 citations
Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia
2001 • 1,239 citations
Platelet Activation in Unstable Coronary Disease
1986 • 1,161 citations
The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary Vasomotion
1995 • 1,123 citations
HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway
2001 • 1,108 citations
Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery Disease
1996 • 1,066 citations
Cellular and molecular mechanisms of endothelial cell dysfunction.
1997 • 1,064 citations
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions
2004 • 1,050 citations
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site
2001 • 1,035 citations
Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease
2001 • 1,016 citations
Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia
1990 • 999 citations
Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques
2001 • 995 citations
HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway
2001 • 994 citations
Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month
1997 • 968 citations
Statin Therapy Accelerates Reendothelialization
2002 • 924 citations
Transplanted cord blood–derived endothelial precursor cells augment postnatal neovascularization
2000 • 908 citations
Translational Control of p27 Kip1 Accumulation During the Cell Cycle
1996 • 864 citations
Ten-Year Mortality from Cardiovascular Disease in Relation to Cholesterol Level among Men with and without Preexisting Cardiovascular Disease
1990 • 834 citations
Small GTP-Binding Proteins and the Regulation of the Actin Cytoskeleton
1994 • 822 citations
Influence of Pravastatin and Plasma Lipids on Clinical Events in the West of Scotland Coronary Prevention Study (WOSCOPS)
1998 • 804 citations
New insights into the pharmacodynamic and pharmacokinetic properties of statins
1999 • 802 citations
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
2001 • 783 citations
Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
1998 • 767 citations
Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.
1995 • 660 citations
Statins Have Biphasic Effects on Angiogenesis
2002 • 659 citations
HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells
2001 • 653 citations
The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
1984 • 631 citations
HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells
2001 • 601 citations
An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro
2001 • 597 citations
The evolving role of statins in the management of atherosclerosis
2000 • 565 citations
In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation
2000 • 558 citations
Single LDL Apheresis Improves Endothelium-Dependent Vasodilatation in Hypercholesterolemic Humans
1997 • 550 citations
HMG-CoA Reductase Inhibitors Improve Endothelial Dysfunction in Normocholesterolemic Hypertension via Reduced Production of Reactive Oxygen Species
2001 • 468 citations
Rho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide Synthase
2002 • 465 citations
Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications.
1989 • 461 citations
Atherosclerotic plaque rupture and thrombosis. Evolving concepts.
1990 • 457 citations
Hyperlipidemia and Coronary Disease
1995 • 444 citations
Bone Marrow–Derived Progenitor Cells Modulate Vascular Reendothelialization and Neointimal Formation
2002 • 434 citations
Rapid Reduction in C-Reactive Protein With Cerivastatin Among 785 Patients With Primary Hypercholesterolemia
2001 • 416 citations
Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase
1999 • 396 citations
Inhibition of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Blocks Hypoxia-mediated Down-regulation of Endothelial Nitric Oxide Synthase
1997 • 393 citations
Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic Mice
2000 • 393 citations
3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Attenuate Vascular Smooth Muscle Proliferation by Preventing Rho GTPase-induced Down-regulation of p27
1999 • 389 citations
Statins Alter Smooth Muscle Cell Accumulation and Collagen Content in Established Atheroma of Watanabe Heritable Hyperlipidemic Rabbits
2001 • 377 citations
Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability
2000 • 377 citations
S‐nitroso‐glutathione inhibits platelet activation in vitro and in vivo
1992 • 330 citations
3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Increase Fibrinolytic Activity in Rat Aortic Endothelial Cells
1998 • 313 citations
Double-Edged Role of Statins in Angiogenesis Signaling
2002 • 307 citations
Neuroprotection mediated by changes in the endothelial actin cytoskeleton
2000 • 283 citations
3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Interfere With Angiogenesis by Inhibiting the Geranylgeranylation of RhoA
2002 • 275 citations
Hsp90 and Caveolin Are Key Targets for the Proangiogenic Nitric Oxide–Mediated Effects of Statins
2001 • 266 citations
Inhibition of Thromboxane Biosynthesis and Platelet Function by Simvastatin in Type IIa Hypercholesterolemia
1995 • 264 citations
Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease
2001 • 254 citations
Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits
2001 • 251 citations
Nitric Oxide Protects Against Leukocyte-Endothelium Interactions in the Early Stages of Hypercholesterolemia
1995 • 243 citations
HMG CoA Reductase Inhibitors Reduce Plasminogen Activator Inhibitor-1 Expression by Human Vascular Smooth Muscle and Endothelial Cells
2000 • 232 citations
Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia
2001 • 179 citations
Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo
1989 • 172 citations
Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis.
1991 • 166 citations
Enhanced Myosin Light Chain Phosphorylations as a Central Mechanism for Coronary Artery Spasm in a Swine Model With Interleukin-1β
1997 • 153 citations
Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells
2003 • 137 citations
Cerivastatin, an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase, Inhibits Endothelial Cell Proliferation Induced by Angiogenic Factors In Vitro and Angiogenesis in In Vivo Models
2002 • 129 citations
Reduction of Platelet Activity Markers in Type II Hypercholesterolemic Patients by a HMG-CoA-Reductase Inhibitor
1999 • 125 citations
Elucidation off the role of plaque instability and rupture in acute coronary events
1995 • 119 citations
HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data
1998 • 113 citations
Endothelial nitric oxide synthase is essential for the HMG‐CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia
2001 • 113 citations
HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins
2000 • 103 citations
Platelet Cytosolic Ca 2+ and Membrane Dynamics in Patients With Primary Hypercholesterolemia
1995 • 81 citations
MEASUREMENT OF C-REACTIVE PROTEIN FOR THE TARGETING OF STATIN THERAPY IN THE PRIMARY PREVENTION OF ACUTE CORONARY EVENTS
2001 • 63 citations
The Pravastatin Inflammation CRP Evaluation (PRINCE): Rationale and design
2001 • 58 citations
Platelet Deposition on Eroded Vessel Walls at a Stenotic Shear Rate Is Inhibited by Lipid-Lowering Treatment With Atorvastatin
1999 • 55 citations
Increased number of high sensitive platelets in hypercholesterolemia, cardiovascular diseases, and after incubation with cholesterol
1995 • 54 citations
Control of signal transduction and morphogenesis by Ras
1995 • 48 citations
Influence of cholesterol-lowering on plasma membrane lipids and function.
1996 • 44 citations
Combination of Fosinopril and Pravastatin Decreases Platelet Response to Thrombin Receptor Agonist in Monkeys
1998 • 36 citations
Platelet α2-adrenergic receptors in hypercholesterolemia: Relationship between binding studies and epinephrine-induced platelet aggregation
1997 • 24 citations
Deleted Work
1955 • 0 citations